The relative gene expression of KLF6-SV1 was statistically significantly higher in CD8+ T-cells of CLL patients as compared to CD8+ T cells derived of myeloma patients (p<0.05) and healthy donors (p = 0.002) (Fig 2). This evidence concerns the gene KLF6 and B-cell chronic lymphocytic leukemia.